Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study.
Shah NP; Talpaz M; Deininger MW; Mauro MJ; Flinn IW; Bixby D; Lustgarten S; Gozgit JM; Clackson T; Turner CD; Haluska FG; Kantarjian H; Cortes JE; British Journal Of Haematology, 2013, vol. 162, issue 4, p 548, ISSN 13652141. ISBN 13652141.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef